EUVIMEDEUVIMED entdecken
Crossref

BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300/H3K27ac/PLK1 axis

Miao Cheng, Juan-Juan Li, Xue-Ni Niu, Lin Zhu, Jin-Yu Liu, Peng-Cheng Jia, Sai Zhu, Hong-Wu Meng, Xiong-Wen Lv, Cheng Huang, Jun Li

Biochemical Pharmacology · 2023

DOI: 10.1016/j.bcp.2023.115497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Miao Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical Univer…. Hauptthemen laut MEDLINE: Nuclear Proteins, Hepatic Stellate Cells. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic fibrosis (HF) is a reversible wound-healing response characterized by excessive extracellular matrix (ECM) deposition and secondary to persistent chronic injury. Bromodomain protein 4 (BRD4) commonly functions as a "reader" to regulate epigenetic modifications involved in various biological and pathological events, but the mechanism of HF remains unclear. In this study, we established a CCl4-induced HF model and spontaneous recovery model in mice and found aberrant BRD4 expression, which was consistent with the results in human hepatic stellate cells (HSCs)- LX2 cells in vitro. Subsequently, we found that distriction and inhibition of BRD4 restrained TGFβ-induced trans-differentiation of LX2 cells into activated, proliferative myofibroblasts and accelerated apoptosis, and BRD4 overexpression blocked MDI-induced LX2 cells inactivation and promoted the proliferation and inhibited apoptosis of inactivated cells. Additionally, adeno-associated virus serotype 8-loaded short hairpin RNA-mediated BRD4 knockdown in mice significantly attenuated CCl4-induced fibrotic responses including HSCs activation and collagen deposition. Mechanistically, BRD4 deficiency inhibited PLK1 expression in activated LX2 cells, and ChIP and Co-IP assays revealed that BRD4 regulation of PLK1 was dependent on P300-mediated acetylation modification for H3K27 on the PLK1 promoter. In conclusion, BRD4 deficiency in the liver alleviates CCl4-induced HF in mice, and BRD4 participates in the activation and reversal of HSCs through positively regulating the P300/H3K27ac/PLK1 axis, providing a potential insight for HF therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsHepatic Stellate CellsHumansMiceAnimalsTranscription FactorsLiver CirrhosisLiverCell Cycle ProteinsBromodomain Containing Proteins

Stichwörter der Autor:innen

BRD4EpigeneticsH3K27acHSCsHepatic fibrosisPLK1

Substanzen

Nuclear ProteinsTranscription FactorsCell Cycle ProteinsBRD4 protein, humanBromodomain Containing Proteins

Autor:innen und Institutionen

  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China. Electronic address: lyuxw@ahmu.edu.cn.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China. Electronic address: huangcheng@ahmu.edu.cn.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China. Electronic address: lj@ahmu.edu.cn.

Zitieren

APA

Cheng, M., Li, J. J., Niu, X. N., Zhu, L., Liu, J. Y., Jia, P. C., Zhu, S., Meng, H. W., Lv, X. W., Huang, C., & Li, J. (2023). BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300/H3K27ac/PLK1 axis. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115497

Vancouver

Cheng M, Li JJ, Niu XN, Zhu L, Liu JY, Jia PC, et al. BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300/H3K27ac/PLK1 axis. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115497

BibTeX
@article{Cheng2023,
  author = {Cheng, Miao and Li, Juan-Juan and Niu, Xue-Ni and Zhu, Lin and Liu, Jin-Yu and Jia, Peng-Cheng and Zhu, Sai and Meng, Hong-Wu and Lv, Xiong-Wen and Huang, Cheng and Li, Jun},
  title = {BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300/H3K27ac/PLK1 axis},
  journal = {Biochemical Pharmacology},
  year = {2023},
  doi = {10.1016/j.bcp.2023.115497}
}
Kostenlos starten →